Cwm LLC Lowers Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Cwm LLC decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 5.1% in the fourth quarter, Holdings Channel reports. The firm owned 8,469 shares of the financial services provider’s stock after selling 458 shares during the period. Cwm LLC’s holdings in iShares Biotechnology ETF were worth $1,151,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the stock. Signaturefd LLC lifted its holdings in iShares Biotechnology ETF by 14.2% during the fourth quarter. Signaturefd LLC now owns 1,120 shares of the financial services provider’s stock worth $152,000 after buying an additional 139 shares during the period. Robbins Farley lifted its holdings in iShares Biotechnology ETF by 14.4% during the fourth quarter. Robbins Farley now owns 25,097 shares of the financial services provider’s stock worth $3,409,000 after buying an additional 3,158 shares during the period. abrdn plc purchased a new stake in iShares Biotechnology ETF during the fourth quarter worth $5,928,000. Bigelow Investment Advisors LLC lifted its holdings in iShares Biotechnology ETF by 73.9% during the fourth quarter. Bigelow Investment Advisors LLC now owns 4,053 shares of the financial services provider’s stock worth $551,000 after buying an additional 1,722 shares during the period. Finally, Calamos Advisors LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter worth $7,648,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.7 %

Shares of IBB opened at $126.49 on Friday. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The stock has a fifty day moving average price of $134.27 and a 200-day moving average price of $129.74.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.